New data from CORAL-BOOST study demonstrate broad and durable immune response; high neutralizing antibody and T cell responses at 6 months post-boost vaccination --
-- Interim results from CORAL-CEPI show good tolerability and immunogenicity in all vaccine-naïve subjects dosed --
-- Data provide further support of Gritstone’s self-amplifying mRNA (samRNA) as platform for infectious disease vaccines --
https://finance.yahoo.com/news/gritstone-presents-positive-results-two-110000906.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.